Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in BCYC — Bicycle Therapeutics PLC

CIK 1000275 TORONTO, A6
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,600
-$56,540 QoQ
Shares Held
2,500
-82.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#85
of 103 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. BCYC ranks #279 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in BCYC

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,600 2,500
2026-03-31 $67,140 14,470
2025-12-31 $75,628 10,682
2025-09-30 $98,553 12,733
2025-06-30 $72,015 10,362
2025-03-31 $152,310 17,940
2024-12-31 $136,822 9,773
2024-09-30 $10,477 463
2024-06-30 $9,371 463
2024-03-31 $7,146 287
2023-12-31 $6,255 346
2023-09-30 $10,747 535
2023-06-30 $9,748 382
2023-03-31 $4,104 193
2022-12-31 $6,244 211
2022-09-30 $4,837 208
2022-06-30 $3,188 190
2022-03-31 $10,838 247
2021-12-31 $9,191 151
2021-09-30 $4,325 104